Featured
Read our handpicked blogs, curated for you.
|
The Enforcement Horizon: August 2, 2026The industry consensus is dominated by the EU AI Act. As of mid-2026, AI systems…
|
The 2026 Industry Consensus: From Policies to EnforcementThe prevailing consensus among global Tier-1 banks is the…
|
The 2026 Industry Consensus: Unified Systems OrchestrationThe prevailing consensus in 2026 is that "more models…
Recent releases
|
Why Pharma’s Data Silos Kill Omnichannel and How to Fix Them
Data silos in pharma are the invisible barrier holding back digital transformation. On paper, Indian companies are investing heavily in omnichannel engagement. They run webinars, WhatsApp campaigns,…
|
From MLR Bottlenecks to Market Speed: Rethinking Pharma Content Ops
Pharma Content Ops is quickly becoming a boardroom topic in India. For years, marketing leaders treated content creation as a tactical function- slides for reps, brochures for conferences, emailers…
|
Next-Best-Action AI in Indian Pharma: From Pilot to Prescription Lift
AI in Indian pharma is one of the most overused phrases in boardrooms today. Every CMO has seen slick vendor slides promising automation, personalization, and cost savings. Yet when you look closely…
|
The Compliance Advantage Turning UCPMP into a Competitive Edge
In most boardrooms, UCPMP is still seen as a regulatory headache. Something for compliance teams to manage, while marketing quietly complains about delays and restrictions. But this view is outdated…
